Literature DB >> 18606092

Another inconvenient truth: combining the risks from obesity and metabolic syndrome with global warming.

Michael Clearfield1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18606092     DOI： 10.1007/s11883-008-0041-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  25 in total

1.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

3.  Statin treatment in children with familial hypercholesterolemia: the younger, the better.

Authors:  Jessica Rodenburg; Maud N Vissers; Albert Wiegman; A S Paul van Trotsenburg; Anouk van der Graaf; Eric de Groot; Frits A Wijburg; John J P Kastelein; Barbara A Hutten
Journal:  Circulation       Date:  2007-07-30       Impact factor: 29.690

4.  C-reactive protein levels and outcomes after statin therapy.

Authors:  Paul M Ridker; Christopher P Cannon; David Morrow; Nader Rifai; Lynda M Rose; Carolyn H McCabe; Marc A Pfeffer; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

Review 5.  Importance of identifying the overweight patient who will benefit the most by losing weight.

Authors:  Gerald M Reaven
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

6.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Authors:  Steven E Nissen; Stephen J Nicholls; Ilke Sipahi; Peter Libby; Joel S Raichlen; Christie M Ballantyne; Jean Davignon; Raimund Erbel; Jean Charles Fruchart; Jean-Claude Tardif; Paul Schoenhagen; Tim Crowe; Valerie Cain; Kathy Wolski; Marlene Goormastic; E Murat Tuzcu
Journal:  JAMA       Date:  2006-03-13       Impact factor: 56.272

Review 7.  Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

Authors:  Paul M Ridker; Peter W F Wilson; Scott M Grundy
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

8.  Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.

Authors:  Paul M Ridker; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Nardev S Khurmi; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Borge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  Am J Cardiol       Date:  2007-10-24       Impact factor: 2.778

9.  Adolescent overweight and future adult coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Pamela Coxson; Mark J Pletcher; James Lightwood; Lee Goldman
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245

10.  Childhood body-mass index and the risk of coronary heart disease in adulthood.

Authors:  Jennifer L Baker; Lina W Olsen; Thorkild I A Sørensen
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245
View more
  1 in total

Review 1.  The "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation?

Authors:  Michael Clearfield; Melissa Pearce; Yasmin Nibbe; David Crotty; Alesia Wagner
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.